Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05618574 · ClinicalTrials.gov registry record · Phase 2
Nitrite Supplementation in Long COVID Patients
A Phase 2 study of Long COVID and Cardiorespiratory Fitness, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 2
- Development phase
- 17
- Enrollment target
- 1
- Study location
NCT05618574 is a Phase 2 study of Long COVID and Cardiorespiratory Fitness that has completed, run by VA Office of Research and Development. The registered enrollment target is 17 participants, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05618574, a Phase 2 study of Long COVID and Cardiorespiratory Fitness, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
Potential benefits of a nitrate-rich juice supplement to improve skeletal muscle function and associated physical capacity will be studied in patients with Long COVID. Consenting patients with Long-COVID will be randomized to receive Beet-It nitrate beverage group versus a nitrate-depleted placebo beverage. Both groups will receive physical therapy at the long COVID Clinic at VAPHS with therapeutic goals to improve strength, balance, inspiratory, and aerobic capabilities. Physical therapy will last for 2 weeks and include 2 or 3 sessions with a physical therapist a week depending on each individual's exercise tolerance. These sessions can take place on-site or at home (or a hybrid combination) All participants will undergo functional assessments and tissue assessments before and after the 14-day study intervention.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT 140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK)
- DIETARY_SUPPLEMENT 210 ml of nitrate-depleted placebo
Study Locations (1)
Pennsylvania
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2023-12-01 |
| Est. Completion | 2025-02-14 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05618574
The ClinicalTrials.gov registry entry for NCT05618574 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,188-participant average among 50 other Long COVID trials with a reported enrollment target (99% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Long COVID appearing as the primary indexed condition, and to 2 interventions - of which 140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK) is the first listed.
NCT05618574 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05618574 about?
NCT05618574 is a clinical study titled "Nitrite Supplementation in Long COVID Patients". Potential benefits of a nitrate-rich juice supplement to improve skeletal muscle function and associated physical capacity will be studied in patients with Long COVID. Consenting patients with Long-COVID will be randomized to receive Beet-It nitrate beverage group versus a nitrate-depleted placebo b...
What is the current status of trial NCT05618574?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 17 participants. The study started on 2023-12-01. Estimated completion is 2025-02-14.
What conditions does trial NCT05618574 study?
This clinical trial studies the following conditions: Long COVID, Cardiorespiratory Fitness.
What interventions are being tested in trial NCT05618574?
The interventions under investigation include: 140 ml per day of Beet-It nitrate beverage (James White Drinks Ltd., Ipswich, UK) (DIETARY_SUPPLEMENT), 210 ml of nitrate-depleted placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05618574?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05618574 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Long COVID
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
NE3107 in Adults With Neurological Symptoms of Long COVID
RECRUITING · Phase 2
-
Study of Chemosensory Enhancement Through Neuromodulation Training (SCENT for Long COVID)
RECRUITING · Phase 2
-
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
RECRUITING · Phase 2
-
AT1001 for the Treatment of Long COVID
RECRUITING · Phase 2
-
LIFT: Life Improvement Trial
RECRUITING · Phase 2
-
A Study to Examine Anktiva for the Treatment of COVID-19.
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.